Biomarck is pleased to announce its inclusion on COVID-19 Drug Treatment Trackers: Milken Institute COVID-19 Treatment and Vaccine Tracker | Artis Ventures

Terms

No warranty and no liability

While Biomarck is making great efforts to include accurate and up-to-date information, we make no representations or warranties, express or implied, as to the accuracy or completeness of the information provided on this Website and disclaim any liability for the use of this site or any site linked to it.  Biomarck may change this site at any time without notice but does not assume any responsibility to update it.  All users agree that all access and use of this Website and any Website linked to from this site and the content thereof is at their own risk. Neither Biomarck nor any other party involved in creating, producing or delivering this Website or on any Website linked to from this site shall be liable in any manner whatsoever for any direct, incidental, consequential, indirect or punitive damages arising out of your access, use or inability to use this Website or any Website linked to from this site, or any errors or omissions in the content thereof.

Forward-Looking Information

This Website may contain forward-looking information.  Such information is subject to a variety of significant uncertainties, including scientific, business, economic and financial factors, and therefore actual results may differ significantly form those presented.

Links

Links to third party pages are provided for convenience only. We do not express any opinion on the content of any third party pages and expressly disclaim any liability for all third party information and the use of it.

Trademarks

All mentioned trademarks are owned by or licensed by Biomarck.

Copyright

The Website of Biomarck and the information contained and referenced therein are for informational purposes only. Any reproduction, retransmission and other use is strictly prohibited. Request for permission to reproduce any information contained on this Website should be addressed to the Company.